Clinical Trial Update: Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

View source ↗

Summary

This update notes the completed clinical trial evaluating chemotherapy with DC-CIK cell-based adoptive cellular therapy in triple-negative breast cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• DC-CIK cell therapy

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Neoplasms, Neoplasm Metastasis | Status: COMPLETED